“We are excited with the progress of our lead program, cLAG3-IL2, and are eager to make the first public presentation about the program at AACR.”
News Archive
IL-2 Program with Bonum’s Drs. John Mulligan and Neela Patel
Business of Biotech
Dec 20, 2023
Podcast
Realizing the Therapeutic Potential of Cytokines by Making them Context Dependent
The Bio Report
Aug 20, 2023
Podcast
Developing the Next Generation of Targeted, Conditionally Active Cytokine Therapeutics
LinkedIn
Mar 30, 2023
Blog